Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients

Respiratory Medicine

Volumn 134, Issue , 2018, Pages 86-91

  Zhou, Fei ^a   Li, Hui ^a   Gu, Li ^a   Liu, Meng ^a   Xue, Chun xue ^a   Cao, Bin ^a   Wang, Chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lymphocytopenia; Nosocomial infection; Risk factor; Severe influenza

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; HYPERTENSIVE FACTOR; LACTATE DEHYDROGENASE;

2009 H1N1 INFLUENZA; ACINETOBACTER INFECTION; ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BURKHOLDERIA CEPACIA INFECTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; GRAM NEGATIVE INFECTION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEMOPTYSIS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; HYPONATREMIA; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; KLEBSIELLA PNEUMONIAE INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG INFILTRATE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORAXELLACEAE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SEPSIS; STAPHYLOCOCCUS INFECTION; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIA; THROMBOCYTOPENIA; BACTERIAL INFECTION; CHINA; CLINICAL TRIAL; COMPLICATION; CROSS INFECTION; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITALIZATION; INFLUENZA; INFLUENZA A VIRUS (H1N1); KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYCOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; BACTERIAL INFECTIONS; CHINA; CROSS INFECTION; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYCOSES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85037647193     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2017.11.017     Document Type: Article

References (43)

1. Joseph, C., Togawa, Y., Shindo, N., Bacterial and viral infections associated with influenza. Influenza Other Respir. Viruses 7:Suppl 2 (2013), 105–113.
2. Wang, X.Y., Kilgore, P.E., Lim, K.A., et al. Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip. Perspect. Infect. Dis., 2011, 2011, 146376.
3. Hong, S.B., Choi, E.Y., Kim, S.H., et al. Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea. Epidemiol. Infect. 141:5 (2013), 1070–1079.
4. Ergonul, O., Alan, S., Ak, O., et al. Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults. BMC Infect. Dis., 14, 2014, 317.
5. Viasus, D., Pano-Pardo, J.R., Cordero, E., et al. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. J. Infect. 62:3 (2011), 193–199.
6. Viasus, D., Pano-Pardo, J.R., Pachon, J., et al. Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes. Med. (Baltimore) 90:5 (2011), 328–336.
7. Estenssoro, E., Rios, F.G., Apezteguia, C., et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am. J. Respir. Crit. Care Med. 182:1 (2010), 41–48.
8. Estenssoro, E., Rios, F.G., Apezteguia, C., et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am. J. Respir. Crit. Care Med. 182:1 (2010), 41–48.
9. Ding, C., Zhang, Y., Yang, Z., et al. Incidence, temporal trend and factors associated with ventilator-associated pneumonia in mainland China: a systematic review and meta-analysis. BMC Infect. Dis., 17(1), 2017, 468.
10. Zhu, J., Zhang, X., Shi, G., et al. Atrial fibrillation is an independent risk factor for hospital-acquired pneumonia. PLoS One, 10(7), 2015, e0131782.
11. Uvizl, R., Kolar, M., Herkel, T., et al. Possibilities for modifying risk factors for the development of hospital-acquired pneumonia in intensive care patients: results of a retrospective, observational study. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 161:3 (2017), 303–309.
12. Stenlund, M., Sjodahl, R., Pia Yngman-Uhlin, R.N., Incidence and potential risk factors for hospital-acquired pneumonia in an emergency department of surgery. Int. J. Qual. Health Care 29:2 (2017), 290–294.
13. Karatas, M., Saylan, S., Kostakoglu, U., et al. An assessment of ventilator-associated pneumonias and risk factors identified in the Intensive Care Unit. Pak J. Med. Sci. 32:4 (2016), 817–822.
14. Yang, S.G., Cao, B., Liang, L.R., et al. Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One, 7(1), 2012, e29652.
15. Li, H., Yang, S.G., Gu, L., et al. Effect of low-to-moderate dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir. Viruses 11:4 (2017), 345–354.
16. Zhang, P.J., Li, X.L., Cao, B., et al. Clinical features and risk factors for severe and critical pregnant women with 2009 pandemic H1N1 influenza infection in China. BMC Infect. Dis., 12, 2012, 29.
17. World Health Organisation. CDC protocol of realtime RTPCR for influenza A(H1N1)[EB/OL]. (April 28 009) [July 28]. http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf?ua=1.
18. Mandell, L.A., Wunderink, R.G., Anzueto, A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44:Suppl 2 (2007), S27–S72.
19. Baron, E.J., Miller, J.M., Weinstein, M.P., et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin. Infect. Dis. 57:4 (2013), e22–e121.
20. Prina, E., Ranzani, O.T., Torres a.community-acquired pneumonia. Lancet 386:9998 (2015), 1097–1108.
21. Stralin, K., Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia. Int. J. Antimicrob. Agents 31:1 (2008), 3–11.
22. Singer, M., Deutschman, C.S., Seymour, C.W., et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016), 801–810.
23. De Pauw, B., Walsh, T.J., Donnelly, J.P., et al. Revised definitions of invasive fungal disease from the european organization for Research and treatment of cancer/invasive fungal infections cooperative group and the national Institute of Allergy and infectious diseases Mycoses study group (EORTC/MSG) consensus group. Clin. Infect. Dis. 46:12 (2008), 1813–1821.
24. Florescu, D.F., Kalil, A.C., The complex link between influenza and severe sepsis. Virulence 5:1 (2014), 137–142.
25. Southeast Asia Infectious Disease Clinical Research N, Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study. Lancet Glob. Health 5:2 (2017), e157–e167.
26. Hotchkiss, R.S., Monneret, G., Payen, D., Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13:12 (2013), 862–874.
27. Koch, R.M., Kox, M., De Jonge, M.I., et al. Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock 47:1 (2017), 5–12.
28. Smith, A.M., Mccullers, J.A., Secondary bacterial infections in influenza virus infection pathogenesis. Curr. Top. Microbiol. Immunol. 385 (2014), 327–356.
29. Didierlaurent, A., Goulding, J., Patel, S., et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205:2 (2008), 323–329.
30. Kasten, K.R., Tschop, J., Adediran, S.G., et al. T cells are potent early mediators of the host response to sepsis. Shock 34:4 (2010), 327–336.
31. Chen, K., Kolls, J.K., T cell-mediated host immune defenses in the lung. Annu. Rev. Immunol. 31 (2013), 605–633.
32. Martignoni, A., Tschop, J., Goetzman, H.S., et al. CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock 29:5 (2008), 591–597.
33. Kelly-Scumpia, K.M., Scumpia, P.O., Weinstein, J.S., et al. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208:8 (2011), 1673–1682.
34. Carcillo, J.A., Dean, J.M., Holubkov, R., et al. Inherent risk factors for nosocomial infection in the long stay critically ill child without known baseline immunocompromise: a post hoc analysis of the CRISIS trial. Pediatr. Infect. Dis. J. 35:11 (2016), 1182–1186.
35. Adrie, C., Lugosi, M., Sonneville, R., et al. Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann. Intensive Care, 7(1), 2017, 30.
36. Guzman-Herrador, B., Molina, C.D., Allam, M.F., et al. Independent risk factors associated with hospital-acquired pneumonia in an adult ICU: 4-year prospective cohort study in a university reference hospital. J. Public Health (Oxf) 38:2 (2016), 378–383.
37. Osman, M.F., Askari R.Infection control in the intensive care unit. Surg. Clin. North Am. 94:6 (2014), 1175–1194.
38. Yokoe, D.S., Anderson, D.J., Berenholtz, S.M., et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect. Control Hosp. Epidemiol. 35:Suppl 2 (2014), S21–S31.
39. Sopena, N., Heras, E., Casas, I., et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study. Am. J. Infect. Control 42:1 (2014), 38–42.
40. Linehan, E., Fitzgerald, D.C., Ageing and the immune system: focus on macrophages. Eur. J. Microbiol. Immunol. (Bp) 5:1 (2015), 14–24.
41. Reade, M.C., Weissfeld, L., Angus, D.C., et al. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm. Med., 10, 2010, 15.
42. Fraenkel, P.G., Anemia of inflammation: a review. Med. Clin. North Am. 101:2 (2017), 285–296.
43. Rouze, A., Cottereau, A., Nseir, S., Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia. Curr. Opin. Crit. Care 20:5 (2014), 525–531.